Oncology biobank and longitudinal sample collection at NYCBS
New York Cancer and Blood Specialists: Clinical Biospecimen Collection for Research Use
This collects and stores blood, tissue, and health information from adults with cancer, people at higher risk, and healthy donors to help researchers test new cancer tests and treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 900000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | NY Health d/b/a New York Cancer and Blood Specialists Academic / other |
| Locations | 1 site (Shirley, New York) |
| Trial ID | NCT07543159 on ClinicalTrials.gov |
What this trial studies
New York Cancer and Blood Specialists is running a centralized oncology biorepository that collects biological samples and linked clinical data over time from adults receiving care, people at high risk, survivors, and healthy donors. The protocol is observational and gathers biospecimens such as blood and tissue for DNA/RNA analysis, protein and biomarker work, tissue microarrays, and genome sequencing. Samples are stored with associated clinical information to support longitudinal translational research and diagnostic or therapeutic development. Collections occur under a broad master protocol with additional project-specific eligibility criteria as needed.
Who should consider this trial
Good fit: Adults aged 18 or older who can give informed consent, including people with benign conditions, diagnosed or suspected cancer, survivors, high-risk individuals, and healthy donors, are eligible to participate.
Not a fit: Participants should not expect direct therapeutic benefit from enrollment, and people under 18 or unable to provide informed consent are not eligible and will not benefit from this protocol.
Why it matters
Potential benefit: If successful, the biobank could speed discovery and validation of new diagnostic tests and treatments for cancer by providing high-quality samples and data to researchers.
How similar studies have performed: Other institutional and national biobanks have supported successful biomarker and genomic discoveries, although impact depends on the quality and use of collected specimens and data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subjects must be at least 18 years of age 2. Subjects must be deemed competent by a qualified clinical study researcher to provide legally documented informed consent 3. Subjects may or may not have active disease at the time of enrollment 4. Biospecimens collected under this protocol may be obtained from subjects with benign conditions, subjects who have been diagnosed with or suspected of having oncological diseases, infectious diseases, auto-immune diseases, endocrine disorders, as well as subjects from healthy normal donors. Exclusion Criteria: 4\) Subjects not meeting the inclusion criteria Additional inclusion and exclusion criteria may exist, specific to individual project plans, for each collection falling under this protocol. These criteria may include genetic mutation status, progression of disease, and prior lines of therapy among others.
Where this trial is running
Shirley, New York
- Nycbs — Shirley, New York, United States (Recruiting)
Study contacts
- Study coordinator: Andrew Lee, MHA
- Email: Biobanking@nycancer.com
- Phone: 16313935767
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.